gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 5 studies
| Studies (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Trials (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Recent Studies (post-2010) (gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate) | Studies (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Trials (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) | Recent Studies (post-2010) (1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid) |
|---|---|---|---|---|---|
| 638 | 31 | 243 | 792 | 16 | 476 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo-Muzquiz, A; Hanaoka, K; Kodadek, T; Lubag, AJ; Sherry, AD | 1 |
| Echner, H; Gharabaghi, A; Heckl, S; Klose, U; Regenbogen, M; Sturzu, A | 1 |
| Echner, H; Gharabaghi, A; Heckl, S; Kalbacher, H; Klose, U; Regenbogen, M; Sturzu, A | 1 |
| Bluemke, DA; Davies-Venn, C; Kim, H; Kim, I; Kim, JS; Lee, SJ; Paik, CH; Yang, BY; Yao, Z | 1 |
| Aid-Launais, R; Chaubet, F; Chauvierre, C; Forero Ramirez, LM; Gobin, E; Journe, C; Le Cerf, D; Letourneur, D; Moraes, FC; Picton, L | 1 |
5 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.
Topics: Contrast Media; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Molecular Structure; Molecular Weight; Oligopeptides; Organometallic Compounds; Peptides; Succinimides | 2008 |
Novel dual labelled nucleus-directed conjugates containing correct and mutant nuclear localisation sequences.
Topics: Cell Line, Tumor; Cell Nucleus; Contrast Media; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Microscopy, Confocal; Nuclear Localization Signals; Organometallic Compounds; Peptides; Spectrometry, Mass, Electrospray Ionization | 2008 |
Novel cell nucleus directed fluorescent tetraazacyclododecane-tetra-acetic acid compounds.
Topics: Active Transport, Cell Nucleus; Antigens, Polyomavirus Transforming; Cell Nucleus; Cell Survival; Cytoplasm; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glioma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Microscopy, Confocal; Nuclear Localization Signals; Organometallic Compounds; Peptides; Spectrometry, Mass, Electrospray Ionization; tat Gene Products, Human Immunodeficiency Virus | 2009 |
64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET: pharmacokinetic study in a rat model of chronic MI.
Topics: Animals; Autoradiography; Chronic Disease; Copper Radioisotopes; Disease Models, Animal; Drug Stability; Electrons; Fibrosis; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Myocardial Infarction; Myocardium; Organometallic Compounds; Positron-Emission Tomography; Rats | 2016 |
Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets.
Topics: Adult; Blood Platelets; Cells, Cultured; Contrast Media; Cross-Linking Reagents; Dextrans; Emulsions; Gadolinium; Healthy Volunteers; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Human Umbilical Vein Endothelial Cells; Humans; Macromolecular Substances; Magnetic Resonance Imaging; Nanoparticles; Organometallic Compounds; Particle Size; Platelet Activation; Polysaccharides; Spectrometry, X-Ray Emission; Thrombosis | 2020 |